EUCTR2014-001438-27-ES进行中（未招募）1 期
The effect of bezafibrate on cholestatic itch - FITCH
Academic Medical Center0 个研究点目标入组 84 人开始时间: 2017年10月10日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •- age > 18 years
- •- understanding of Dutch, German, English, Spanish or Italian language
- •- Diagnosis of PBC, PSC or SSC as defined by EASL clinical practice guidelines of cholestasis 2009
- •- itch without primary dermatologic abnormalities and with an intensity score of 5 of higher on a scale from 0 to 10, scored twice within the week before start of the treatment
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 84
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- concomitant antipruritic therapy
- •- pregnancy
- •- cholestasis due to obstruction that requires invasive desobstructive treatment within the time scope of the study (5 weeks), such as ERCP or surgery
- •- use of opiates
研究者
相似试验
已完成
2 期
The effect of bezafibrate on cholestatic itchprimary biliary cirrhosis10019654primary sclerosing cholangitisNL-OMON42182Academisch Medisch Centrum52
进行中（未招募）
不适用
The effect of bezafibrate on itch in a subset of liver diseasesPrimary biliary cirrhosis (PBC)Primary sclerosing cholangitis (PSC)Secondary sclerosing cholangitis (SSC)EUCTR2014-001438-27-NLAcademic Medical Center84
招募中
不适用
The effect of bezafibrate on itch in liver diseasePrimary biliary cirrhosis (PBC)Primary sclerosing cholangitis (PSC)Secondary sclerosing cholangitis (SSC)NL-OMON22138Academic Medical Center, Amsterdam84
Unknown
3 期
The Effect of Bezafibrate on Cholestatic ItchSecondary Sclerosing CholangitisPrimary Sclerosing CholangitisPrimary Biliary CholangitisNCT02701166Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)84
已完成
不适用
Effect of bezafibrate on endothelial dysfunction induced by postprandial hypelipidemiaJPRN-UMIN000012557Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences20